TY - JOUR
T1 - The future of pancreatology
T2 - how to go where we have never been before
AU - Urrutia, Raul
N1 - Funding Information:
The author dedicates this work to Professor Dr. Hans Gunther Beger. Dr. Gwen Lomberk kindly made suggestions on the manuscript and illustrations. This work was partially funded by NIDDK grants to R.U.
PY - 2007/10
Y1 - 2007/10
N2 - The current article is part of a series of manuscripts, which together serve as a never-perfect yet candid attempt to honor the remarkable scientific stature of Professor Hans Gunther Beger. The challenge posed to the author has been to meditate on the future of pancreatology. In the following paragraphs, to the exclusion of no other, we provide an approach to future discoveries in our field. This approach combines the large scope of the new biology (eg, genomics) with the analytical power of conventional, hypothesis-driven, molecular cell biology of individual laboratories to build comprehensive functional models of normal and diseased pancreatic cell populations. In addition, the potential challenges that both the size of our field and current research funding offer to scientists focused on the pancreas are discussed. It is the author's hope that the readers will not only meditate on the reflections offered here but, when in agreement with the positions stated, will help to implement a road map that can make our scientific field better. Never forget-the lives of our patients depend on what we do.
AB - The current article is part of a series of manuscripts, which together serve as a never-perfect yet candid attempt to honor the remarkable scientific stature of Professor Hans Gunther Beger. The challenge posed to the author has been to meditate on the future of pancreatology. In the following paragraphs, to the exclusion of no other, we provide an approach to future discoveries in our field. This approach combines the large scope of the new biology (eg, genomics) with the analytical power of conventional, hypothesis-driven, molecular cell biology of individual laboratories to build comprehensive functional models of normal and diseased pancreatic cell populations. In addition, the potential challenges that both the size of our field and current research funding offer to scientists focused on the pancreas are discussed. It is the author's hope that the readers will not only meditate on the reflections offered here but, when in agreement with the positions stated, will help to implement a road map that can make our scientific field better. Never forget-the lives of our patients depend on what we do.
KW - Molecular cell biology
KW - Pancreatology
UR - http://www.scopus.com/inward/record.url?scp=34548817027&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548817027&partnerID=8YFLogxK
U2 - 10.1016/j.amjsurg.2007.05.034
DO - 10.1016/j.amjsurg.2007.05.034
M3 - Article
C2 - 17903433
AN - SCOPUS:34548817027
SN - 0002-9610
VL - 194
SP - S153-S157
JO - American journal of surgery
JF - American journal of surgery
IS - 4 SUPPL.
ER -